X4 Pharmaceuticals (XFOR) Exec Chairman Craig Adam R Sells Shares

What Happened

• Craig Adam R, Executive Chairman and Director of X4 Pharmaceuticals (XFOR), disposed of 47,436 shares on 2026-08-12 in open-market sales for total proceeds of approximately $210,829 (weighted average price $4.44). The filing indicates the sales were made to cover the insider's personal income tax obligation upon settlement of a restricted stock unit (RSU) award.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-13 (timely filing).
• Transaction type/code: Sale (S) — open-market/private sale.
• Share quantity and proceeds: 47,436 shares sold for ~$210,829; weighted average price reported $4.44.
• Price range: shares were sold in multiple transactions at prices between $4.33 and $4.55; the filer offers to provide the per-price breakdown on request.
• Holdings note: the filing states that 193,254 of the reported shares represent restricted stock units (RSUs). (The total post-transaction share count is not provided here.)
• Footnote: sale was to cover personal income tax withholding upon RSU settlement (routine tax-related sale).

Context

• Sales made solely to satisfy tax obligations on RSU settlement are common and are generally considered routine administrative transactions rather than directional bets on the company. This was a disposal, not a purchase or option exercise.